Intellectual Property Updates
NaNots are a new class of medicine: injectable nanoparticles that clear specific pathogenic molecules from blood, such as tumor-generated immune inhibitors.
We invented this technology and have received three patents to date; our most recent is very broad, covering virtually our entire therapeutic domain.
UPDATE: We were just informed that our 4th patent will be granted soon, for “programmable soluble target extractors” – the next generation of our platform.
EU Trademarks granted (Austria, Belgium, Denmark, Finland, France, Germany, Great Britain, Greece, Ireland, Italy, Luxembourg, the Netherlands, Portugal, Spain and Sweden.)